LEXINGTON, Mass.--(BUSINESS WIRE)--BioScale, Inc. a life science company that develops high-precision, sensitive protein analysis technology, today announced that data from its internal research program and collaborations with the National Cancer Institute (NCI) Antibody & Protein Purification Unit and the Frank McCormick laboratory at UCSF Helen Diller Family Comprehensive Cancer Center were accepted for presentation and publication in the proceedings of the 104th Annual Meeting of the American Association for Cancer Research (AACR). The Conference will be held at the Walter E. Washington Convention Center in Washington, DC from April 6 - April 10, 2012. Details of the four poster presentations focusing on signal transduction pathway analysis, tumor fingerprinting, rapid assay development and cell line screening of siRNA sequences for viability and pathway disruption are presented below.
